December 14th, 2021

9:40 am Utilizing Precision Genetic Medicine to Treat Rare Neurodevelopmental Diseases: Focusing on Rett Syndrome
Chrisopher U Missling
President & CEO, Anavex Life Sciences
Synopsis
Requirement of clear understanding of target engagement
Importance of predictive biomarker of response correlating with efficacy
Relevance of appropriate efficacy endpoints

https://neurodevelopmental-drug-development.c...m/day-two/